Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 1376 - 1400 of 3621 in total

Alemtuzumab

Alemtuzumab is a humanized monoclonal antibody specific to lymphocyte antigens. It is a recombinant DNA-derived humanized monoclonal antibody (Campath-1H) that is directed against the 21-28 kD cell surface glycoprotein, CD52. The Campath-1H antibody is an IgG1 kappa with the human variable framework and constant regions, and complementarity-determining regions from a...
Approved
Investigational
Matched Products: … MABCAMPATH INF SOL ICIN 30 MG/ML KONS 1 ML 3 FLK (10 MG/ML KONSANTRE 3 AMP) …

Empagliflozin

Empagliflozin is an inhibitor of sodium-glucose co-transporter-2 (SGLT2), the transporters primarily responsible for the reabsorption of glucose in the kidney. It is used clinically as an adjunct to diet and exercise, often in combination with other drug therapies,[L13673,L13679,L11479] for the management of type 2 diabetes mellitus. The first known inhibitor...
Approved
Matched Mixtures name: … กลีแซมบี 10 มก./5 มก. ... GLYXAMBI® 10 MG/ 5 MG ... GLYXAMBI® 10 MG/ 5 MG …
Matched Products: … JARDIANCE 10 MG ... JARDIANCE 10 MG FILM KAPLI TABLET, 30 ADET …

Nitrendipine

Nitrendipine is a calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
Approved
Investigational
Matched Mixtures name: … ENEAS 10/20MG ... ENEAS 10/20MG ... ENEAS® 10/20 MG COMPRIMIDOS …
Matched Products: … CONETRIN 10 MG ... NITRENDIPIN AL 10 ... ไดเทรนิล (ชนิดเม็ด10 มก.) …

Prasugrel

Prasugrel, a thienopyridine derivative, is a platelet activation and aggregation inhibitor structurally and pharmacologically related to clopidogrel and ticlopidine. Similar to clopidogrel, prasugrel is a prodrug that requires enzymatic transformation in the liver to its active metabolite, R-138727. R-138727 irreversibly binds to P2Y12 type ADP receptors on platelets thus preventing...
Approved
Matched Salts cas: … 952340-40-8 …
Matched Products: … PERKUNAL 10 ... PRASUGREL BETA 10 MG FTA ... Prasulan 10 mg-Filmtabletten …

Cisplatin

Cisplatin, cisplatinum or cis-diamminedichloroplatinum(II) (CDDP) is a platinum-based chemotherapy drug used to treat various types of cancers, including sarcomas, some carcinomas (e.g. small cell lung cancer, and ovarian cancer), lymphomas and germ cell tumors. It was the first member of its class, which now also includes carboplatin and oxaliplatin.
Approved
Matched Products: … CISPLATINO INYECTABLE 10 MG / 10 ML ... CISPLATIN DBL 10 ML 10 MG FLAKON, 1 ADET ... CISPLATIN 10 …

Nitroglycerin

Nitroglycerin, also known as glyceryl trinitrate, is an organic nitrate and a vasodilating agent that was first discovered in 1847. Originally used to dynamite, its antianginal effects were identified in the late 1860s after it produced headaches in factory workers while workers with angina pectoris or heart failure experienced relief...
Approved
Investigational
Matched Products: … TRİNİTY 10 MG/10 ML I.V. İNFÜZYONLUK ÇÖZELTİ, 10 AMPUL ... PERLINGANIT 10 MG/10 ML İNFÜZYONLUK ÇÖZELTİ, 10 ADET ... DEPONIT NT 10 TRANSDERMAL FLASTER, 10 ADET …

Rocuronium

Rocuronium (rapid onset-curonium) is a desacetoxy analogue of vecuronium with a more rapid onset of action. It is an aminosteroid non-depolarizing neuromuscular blocker or muscle relaxant used in modern anaesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Introduced in 1994, rocuronium has...
Approved
Matched Iupac: … 1-[(1R,2S,3aS,3bR,5aS,7S,8S,9aS,9bS,11aS)-1-(acetyloxy)-7-hydroxy-9a,11a-dimethyl-8-(morpholin-4-yl)- …
Matched Products: … ANTARİN 100 MG/10 ML IV ENJEKSİYONLUK ÇÖZELTİ, 10 ADET ... MUSCOBLOC 100 MG/10 ML İ.V. ENJEKSİYONLUK ÇÖZELTİ, 10 ADET ... MUSCURON 100 MG/10 ML ENJEKSIYON IÇIN ÇÖZELTI IÇEREN FLAKON,10 FLAKON …

Primidone

Primidone is an anticonvulsant used to treat essential tremor as well as grand mal, psychomotor, and focal epileptic seizures. Primidone was developed by J Yule Bogue and H C Carrington in 1949. Primidone was granted FDA Approval on 8 March 1954.
Approved
Vet approved
Matched Description: … [A189522] Primidone was granted FDA Approval on 8 March 1954.[L11112] …

Olmesartan

Olmesartan belongs to the angiotensin II receptor blocker (ARB) family of drugs, which also includes telmisartan, candesartan, losartan, valsartan, and irbesartan. ARBs selectively bind to angiotensin receptor 1 (AT1) and prevent the protein angiotensin II from binding and exerting its hypertensive effects, which include vasoconstriction, stimulation and synthesis of aldosterone...
Approved
Investigational
Matched Mixtures name: … OLMEDIPIN® AM 20/10 ... ILTUXAM ® 20 MG - 10 MG ... OLMETECANLO 40 MG / 10 MG …
Matched Products: … STAROLMI® 10 ... Mencord 10 mg Filmtabletten ... Olmeblo 10 mg-Filmtabletten …

Piroxicam

A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily.
Approved
Investigational
Matched Products: … GRAZEO 10 ... ROSIC 10 ... OVTELIS 10 …

Gliclazide

Gliclazide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It has been classified differently according to its drug properties in which based on its chemical structure, gliclazide is considered a first-generation sulfonylurea due to the structural presence of a sulfonamide group able to release...
Approved
Matched Description: … 10 weeks of glucose control). ... glucose, postprandial blood glucose and glycosolated hemoglobin (HbA1c) levels (reflective of the last 8- ... extensively metabolized by the liver; its metabolites are excreted in both urine (60-70%) and feces (10 …

Ebastine

Ebastine is under investigation for the treatment of Irritable Bowel Syndrome (IBS). Ebastine has been investigated for the treatment of Urticaria.
Approved
Investigational
Matched Products: … EBAFIT 10 MG FILM KAPLI TABLET, 10 ADET ... KESTINE TABLET 10 mg ... EBARGEN TABLETAS 10 MG …

Ustekinumab

Ustekinumab is a human immunoglobulin (Ig) G1 kappa monoclonal antibody directed against interleukin(IL)-12 and IL-23, which are cytokines that are involved in immune and inflammatory responses. It was generated via recombinant human IL-12 immunization of human Ig (hu-Ig) transgenic mice. It is a targeted biologic disease-modifying anti-rheumatic drug (bDMARDs) that...
Approved
Investigational

Umeclidinium

Umeclidinium is a long-acting muscarinic antagonist (LAMA) used as a maintenance treatment for symptoms of chronic obstructive pulmonary disease (COPD). COPD is a progressive obstructive lung disease characterized by shortness of breath, cough, sputum production, and chronically poor airflow with a forced expiratory volume in 1 second (FEV1) of less...
Approved

Alprostadil

Alprostadil is a chemically-identical synthetic form of prostaglandin E1 (PGE1), a potent vasodilator produced endogenously. In 1996, the FDA approved the use of alprostadil, administered either with an intracavernosal injection or an intraurethral suppository, for the treatment of erectile dysfunction, and it is used in men for whom oral treatment...
Approved
Investigational
Matched Products: … CAVERJECT POWDER FOR INJECTION 10 mcg/ml ... Caverject Dual 10 µg - Zweikammerzylinderampullen ... Caverject 10 µg - Trockenstechampulle mit Lösungsmittelspritze …

Oxybenzone

Oxybenzone is an organic compound used in sunscreens. It is a derivative of benzophenone. It forms colorless crystals that are readily soluble in most organic solvents. It is used as an ingredient in sunscreen and other cosmetics because it absorbs UV-A ultraviolet rays.
Approved
Investigational
Matched Mixtures name: … Givenchy Photo Perfexion Evanescent Fluid Fondation SPF 10 Light Amber 8 ... Sb 10 SPF 30 ... Hand Cream SPF 10 …

Emapalumab

Emapalumab, also known as NI-0501, is a fully human monoclonal antibody that targets interferon gamma. Emapalumab development was sponsored by NovImmune SA, further developed by Sobi and FDA approved on November 20, 2018.[A38676, L4840] The approval of emapalumab was followed by the designation of orphan drug, priority review and breakthrough...
Approved
Investigational

Sugammadex

Sugammadex is a selective relaxant binding agent indicated for reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide during surgery. Rocuronium bromide and vecuronium bromide are neuromuscular blocking medications that cause temporary paralysis and are especially useful for general anesthesia, ventilation, or tracheal intubation that patients may require...
Approved
Matched Products: … ENJEKSİYONLUK ÇÖZELTİ, 10 ADET ... ENJEKSİYONLUK ÇÖZELTİ, 10 ADET ... ENJEKSİYONLUK ÇÖZELTİ, 10 ADET …

Vecuronium

Monoquaternary homolog of pancuronium. A non-depolarizing neuromuscular blocking agent with shorter duration of action than pancuronium. Its lack of significant cardiovascular effects and lack of dependence on good kidney function for elimination as well as its short duration of action and easy reversibility provide advantages over, or alternatives to, other...
Approved
Investigational
Matched Iupac: … 1-[(1R,2S,3aS,3bR,5aS,7S,8S,9aS,9bS,11aS)-1,7-bis(acetyloxy)-9a,11a-dimethyl-8-(piperidin-1-yl)-hexadecahydro …
Matched Products: … VECRON 10 MG İ.V. ... NORCURON 10 MG ... BROMURODE VECURONIO 10 MG …

Mavacamten

Mavacamten is a myosin inhibitor indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM). It received initial US FDA approval in 2022, and it is one of the first myosin inhibitors to be used in humans. Mavacamten was also approved...
Approved
Investigational

Milnacipran

Milnacipran is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) and like many agents in this category was originally developed for and continues to be approved and indicated for the treatment of depression [F3928, F3934, A175786, A175951]. Furthermore, in 2009 the US FDA approved milnacipran for the additional indication of...
Approved
Investigational

Fingolimod

Multiple sclerosis, or MS, is a devastating inflammatory disease that often progresses and causes severe neurological, physical, and cognitive effects. Fingolimod is a sphingosine 1-phosphate receptor modulator for the treatment of relapsing-remitting multiple sclerosis. It was developed by Novartis and initially approved by the FDA in 2010. Fingolimod was also...
Approved
Investigational

Neisseria meningitidis group Y capsular polysaccharide tetanus toxoid conjugate antigen

Approved

Rizatriptan

Rizatriptan is a second-generation triptan and a selective 5-HT1B and 5-HT1D receptor agonist. Used in the treatment of migraines, rizatriptan was first approved in the US in 1998. Rizatriptan is available in oral tablets, orally disintegrating tablets (wafers), and oral film formulations.
Approved
Matched Products: … MİGREOUT 10 MG EFERVESAN TABLET, 10 ADET ... RIZATRIPTAN-NEURAX 10 MG ... Maxalt 10 mg - Tabletten …

Rabeprazole

Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. It is a prodrug - in the acid environment of the parietal cells it turns into active sulphenamide form. Rabeprazole inhibits the H+, K+ATPase of the coating gastric cells and dose-dependent oppresses basal and stimulated gastric acid secretion.
Approved
Investigational
Matched Mixtures name: … RABEDIC 10/75 MG MR KAPSÜL, 20 ADET ... RABEDIC 10/75 MG MR KAPSÜL, 30 ADET ... RABELIS PLUS 20/10 MG KAPSUL, 30 ADET …
Matched Products: … BAROLE 10 ... PARIET (10 MG) ... PARIET TABLET 10 mg …
Displaying drugs 1376 - 1400 of 3621 in total